Lupin Pharmaceuticals has obtained FDA approval for Suprax (Cefixime) for oral suspension, 500 mg/5mL and anticipates initiating product shipment shortly. Suprax oral suspension is indicated for otitis media, acute exacerbation of chronic ...
Tags: Lupin Pharmaceuticals, FDA, Suprax
Lupin Pharmaceuticals has received FDA approval for Suprax (Cefixime) capsules 400mg and will initiate the shipment of the product shortly. The approval will expand Lupin's range of Suprax dosage forms available to treat the approved ...